Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Hims & Hers Surges on JPMorgan Upgrade and GLP-1 Expansion
Hims & Hers stock jumped 9% after JPMorgan gave an overweight rating and $35 target. The company now offers Eli Lilly's Zepbound and Foundayo through LillyDirect.
CoreWeave CEO Cashes Out $35.8M Amid AI Cloud Rally
CoreWeave CEO Michael Intrator sold $35.8 million in shares this week, while the company announced major customer deals and debt financing.
StoneCo Shares Tumble 16% After Ex-Dividend Date for $2.53 Special Payout
StoneCo (STNE) shares dropped 16.3% to $12.18 on Friday after trading ex-dividend for a $2.53 special cash dividend, totaling R$3.08 billion. The payout follows the sale of Linx and 2025 earnings growth.
Nasdaq Hits Record as Intel AI Outlook Fuels Chip Rally, Dow Dips
The Nasdaq hit a new intraday high Friday as Intel's strong Q2 outlook sparked a broad chip rally, while the Dow slipped. Consumer sentiment hit a record low, keeping inflation worries front and center.
Lilly's Oral Obesity Drug Foundayo Trails Novo Nordisk's Wegovy in Early Prescription Data
Eli Lilly's Foundayo prescriptions hit 3,707 in week two, well behind Novo Nordisk's Wegovy. Lilly shares dropped 4%, while Novo gained 6%. Analysts advise caution on early figures.
Cheetah Net Soars on Acquisition Deal, Heavy Trading Volume
Cheetah Net shares jumped on heavy volume after agreeing to buy Super International Trading for $4.98M in cash, with a $10M annual revenue target.
FreeCast Soars on DIRECTV Multifamily Deal, Financing Risks Remain
FreeCast shares jumped 23.8% on a DIRECTV multifamily deal. Maxim Group initiated with Buy and $6 target. Dilution risks persist per SEC filings.
Novo Nordisk Wegovy Pill Prescriptions Surge Past Eli Lilly's Foundayo in Early Launch Race
Novo Nordisk's Wegovy pill recorded 18,410 U.S. prescriptions in its second week, far outpacing Eli Lilly's Foundayo at 3,707, according to IQVIA data. Novo shares rose, Lilly fell.
Elong Power Stock Surges 26% on Heavy Volume Amid Turnaround Efforts
Elong Power shares surged 26% on heavy trading volume, as the company released its annual report showing narrowed losses and a strategic pivot to an asset-light battery storage model.
Scinai Immunotherapeutics Soars 82% on $2.61M Private Placement for CDMO Expansion
Scinai Immunotherapeutics shares surged 82% after announcing a $2.61M private placement to support its CDMO expansion and immunotherapy programs.
Organon Surges on Report of $13B Sun Pharma Bid
Organon shares jumped 25% Friday after a report that Sun Pharma made a $13 billion all-cash takeover offer, backed by $12 billion in bank financing.
